DCTH: Delcath Systems, Inc.
Performance
DCTH +134.61%
Watchlist
Select an item
Summary
DCTH at a glance
DCTH returned +134.61% over the past year and +11.55% a year over five years. Its worst drop in that year was -21.68%, smaller than 76% of stocks on Redstone, and its Sharpe ratio of 1.63 beats 94% of stocks on Redstone. It pays no dividends.
Current Drawdown
0.00%
Rolling Volatility
126.85%
Actions
Metrics
Risk Indicators
Alpha82.52%
Beta1.67x
Sharpe1.63
Sortino3.45
Omega1.41
Calmar6.21
Martin11.08
Profile
About DCTH
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers.
- Sector
- Health Care
- Industry
- Surgical & Medical Instruments & Apparatus
- Market cap
- $703M
- Listed
- Oct 2000
- Employees
- 156
- Headquarters
- Queensbury, NY
- Website
- delcath.com
Comparisons